로딩 중…
지수 로딩 중…
Daihan Pharmaceutical Co.,Ltd.
023910· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩25,500-1.73%
2026-06-19
Price Chart
Daihan Pharmaceutical Co.,Ltd.-14.43%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 153.00B KRW |
| Revenue | 211.44B KRW |
| Net Income | 4.41B KRW |
| Total Assets | 352.90B KRW |
| Net Assets | 301.16B KRW |
| Employees | 675 |
| Value | |
| P/E | 34.69x |
| P/B | 0.51x |
| P/S | 0.72x |
| EV/EBITDA | 48.16x |
| FCF Yield | 0.31% |
| Profitability | |
| ROE | 1.46% |
| ROA | 1.25% |
| Op. Margin | 14.10% |
| Revenue Growth | 5.66% |
| Earnings Growth | -8.70% |
| Financial Health | |
| Debt Ratio | 117.18% |
| Total Debt | 0 KRW |
| FCF | 481.5M KRW |
| Cash | 47.15B KRW |
| Current Ratio | 3.61x |
| Net Debt/EBITDA | -21.45x |
| Dividend | |
| Div. Yield | 3.85% |
| Div. Growth | 11.11% |
| Performance | |
| 1Y Return | -14.43% |
| 1M Return | -5.90% |
| From 52W High | -24.89% |
| 1Y MDD | -24.93% |
| Trading | |
| Volume | 25,327 shares |
| Foreign Own. | 18.31% |
| Per Share | |
| EPS | 4,496 KRW |
| BPS | 51,218 KRW |
Company Info
Established in 1963 and listed on KOSDAQ in 1994, Daehan Pharm is a specialty pharmaceutical company manufacturing and selling infusion solutions. It primarily produces infusion solutions, ampoules, and nutritional solutions for medical facilities, and also enters the pharmacy market with OTC products like contact lens cleaning solutions. The company has established a mass production system and pursues cost reduction through continuous infrastructure development, including automated production lines and warehouses. Daehan Pharm's headquarters are located in Yeongdeungpo-gu, Seoul.